Article
SOX9 acts as a dynamic pioneer factor inducing stable changes in the chromatin landscape to reprogram endothelial cells
2020-09-11
Abstract excerpt
The transcription factor SOX9 is expressed in multiple tissues during embryogenesis and directs developmental processes. SOX9 is activated upon endothelial-to-mesenchymal transition (EndMT) in the developing heart, but its role in regulating this process is less clear. Using human umbilical vein endothelial cells as an EndMT model, we show that SOX9 expression alone is sufficient to activate mesenchymal enhancers...
Topics
Open a Topic to create a Post that cites this publication.
- Circular RNAs in diseases
- Congenital heart defects research
- Cytokine Signaling Pathways and Interactions
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Genomics and Chromatin Dynamics
- MicroRNA in disease regulation
- NF-κB Signaling Pathways
- Osteoarthritis Treatment and Mechanisms
Identifiers and source
- Literature Corpus work
- d9a0e4d5-5e82-5601-91f8-48e46c22ff68
- DOI
- 10.1101/2020.09.11.293993
